NCT01030965 - 28-day Repeat Dose Study of GSK573719 | Biotech Hunter

Enrollment

285

Participants

Timeline

Start Date

December 15, 2009

Primary Completion Date

July 4, 2010

Study Completion Date

July 4, 2010

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

GSK573719 125mcg

125mcg once-daily

DRUG

GSK573719 250mcg

250mcg once-daily

DRUG

GSK573719 500mcg

500mcg once-daily

DRUG

Placebo

once-daily

Trial Locations (20)

10138

GSK Investigational Site, Tallinn

10787

GSK Investigational Site, Berlin

13125

GSK Investigational Site, Berlin

13419

GSK Investigational Site, Tallinn

13619

GSK Investigational Site, Tallinn

14057

GSK Investigational Site, Berlin

19055

GSK Investigational Site, Schwerin

20253

GSK Investigational Site, Hamburg

22927

GSK Investigational Site, Großhansdorf

28207

GSK Investigational Site, Charlotte

29303

GSK Investigational Site, Spartanburg

29379

GSK Investigational Site, Union

42431

GSK Investigational Site, Madisonville

51014

GSK Investigational Site, Tartu

65187

GSK Investigational Site, Wiesbaden

15-027

GSK Investigational Site, Bialystok

Unknown

GSK Investigational Site, Bialystok

97-540

GSK Investigational Site, Gidle

31-023

GSK Investigational Site, Krakow

20-637

GSK Investigational Site, Lublin